# A Study to Explore Correlation Between Symptoms and Signs of Polycystic Ovarian Syndrome (PCOS) and Risk of Over-response to Ovarian Stimulation

> **NCT02607293** · — · COMPLETED · sponsor: **Merck KGaA, Darmstadt, Germany** · enrollment: 1064 (actual)

## Conditions studied

- Polycystic Ovary Syndrome

## Interventions

- **DRUG:** Gonal-f®
- **DRUG:** Long GnRH agonist
- **DRUG:** GnRH antagonist

## Key facts

- **NCT ID:** NCT02607293
- **Lead sponsor:** Merck KGaA, Darmstadt, Germany
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12-31
- **Primary completion:** 2017-03-16
- **Final completion:** 2017-06-28
- **Target enrollment:** 1064 (ACTUAL)
- **Last updated:** 2018-06-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02607293

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02607293, "A Study to Explore Correlation Between Symptoms and Signs of Polycystic Ovarian Syndrome (PCOS) and Risk of Over-response to Ovarian Stimulation". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02607293. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*